Endocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting

April 20, 2018

Congratulations to Amit Tirosh, MD, neuroendocrine cancer physician and researcher, whose work was recognized for excellence at the Endocrinology Society’s 2018 Annual Meeting. Dr. Tirosh will soon be establishing and leading a new NET center at …

READ MORE

Please Help Pass a Bill That Could Result in Early Diagnosis for Neuroendocrine Cancer Patients — Deadline Extended to April 16

April 13, 2018

NET patients, friends and families – we need your help! Greta Stifel, founder of the Stifle Cancer Foundation, NET patient thriver, advocate and political activist, has created and submitted to the State of Connecticut Public Health Committee and…

READ MORE

Please Help Pass a Bill That Could Result in Earlier Diagnosis for Neuroendocrine Cancer Patients

April 3, 2018
 DEADLINE EXTENDED TO APRIL 16

NET patients, friends and families – we need your help! Greta Stifel, founder of the Stifle Cancer Foundation, NET patient thriver, advocate and political activist, has created and submitted to the State of Connecticut

READ MORE

Clinical Nurse Educator Program Established for Neuroendocrine Tumor Patients on Xermelo

March 13, 2018

Are you a neuroendocrine tumor patient who is taking or has been prescribed Xermelo? Lexicon Pharmaceuticals is now offering a new Clinical Nurse Educator Program (CNE) available to you at no charge. Click here to read more

READ MORE

Exciting News about Edward M. Wolin, MD, CCF’s  Co-Medical Director

February 6, 2018

It is with great pleasure that the Carcinoid Cancer Foundation announces that Edward M. Wolin, MD, Co-Medical Director of CCF, has been named Director of the Center for Carcinoid and Neuroendocrine Tumors at The Mount Sinai Hospital in New York City, …

READ MORE

Facebook Live with Neuroendocrine Cancer Expert Richard R.P. Warner, MD

February 3, 2018

In celebration of the Carcinoid Cancer Foundation’s 50th anniversary in March 2018, CCF presented a Facebook LIVE event with Richard R.P. Warner, MD, founder of CCF and one of the world’s leading neuroendocrine cancer experts, on February 2, 2018.…

READ MORE

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).…

READ MORE

New NET Fellowship Established at Stanford University School of Medicine

January 3, 2018

Stanford University School of Medicine in California has established a new one-year Neuroendocrine Tumor (NET) Fellowship under the direction of NET expert Pamela L. Kunz, MD, who is Director of the Stanford Neuroendocrine Tumor Program and a Board…

READ MORE

Arizona Symposium on Neuroendocrine Cancer — Join In-Person or Online

December 1, 2017

The Arizona Carcinoid & Neuroendocrine Foundation invites you to attend A Symposium on Neuroendocrine Cancer on Saturday, December 16, 2017.  Attendance is available in-person at Banner MD Anderson Cancer Center in Gilbert, Arizona, or online.…

READ MORE

Call for Nominations: 8th Annual Warner Advocacy Award

November 10, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. The deadline for nominations is November 29. Read more and nominate your NET hero/heroine.…

READ MORE